Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
To examine the changes of bone mineral density and bone turnover markers after Bonviva treatment in osteoporotic patients
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Osteoporosis | Experimental |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Ibandronic acid, vitamin D | Device |
|
| Measure | Description | Time Frame |
|---|---|---|
| Changes of bone mineral density | To examine the changes of bone mineral density for the purpose of the effectiveness of the drug | every 4-6 months |
| Measure | Description | Time Frame |
|---|---|---|
| Improvement of bone turnover markers | To examine the changes of bone turnover markers for the purpose of the effectiveness of the drug | Every 3-6 months |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Yukio Nakamura, MD, PhD | Contact | +81-263-37-2659 | yxn14@aol.jp |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Showa Inan General Hospital | Recruiting | Komagane | Nagano | 399-4117 | Japan |
Not provided
| ID | Term |
|---|---|
| D010024 | Osteoporosis |
| ID | Term |
|---|---|
| D001851 | Bone Diseases, Metabolic |
| D001847 | Bone Diseases |
| D009140 | Musculoskeletal Diseases |
| D008659 | Metabolic Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| D009750 |
| Nutritional and Metabolic Diseases |